Also trades as: CO (NYSE) · $vol 1M

$0.95

+0.00 (+0.00%)

Weekly Expected Move ±0.2%

$1 $1 $1 $1 $1

OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 59 · $127.4M mcap · 117M float · 0.0042% daily turnover · Short 58% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$1.2B +7.2% ▲

5Y CAGR: +10.3%

Gross Profit

$1.1B +8.1% ▲

5Y CAGR: +11.4%

Operating Income

$609M +11.7% ▲

5Y CAGR: +18.1%

Net Income

$501M -1.4% ▼

5Y CAGR: +31.8%

EPS (Diluted)

$4.12 -1.4% ▼

5Y CAGR: +21.0%

EBITDA

$657M +10.6% ▲

5Y CAGR: +14.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2018	FY2019	FY2020	FY2021	FY2022
Revenue	$937M	$987M	$1.2B	$1.2B	$1.2B
YoY Growth	+23.3%	+5.3%	+23.8%	-5.1%	+7.2%
Cost of Revenue	$181M	$186M	$189M	$179M	$183M
Gross Profit	$755M	$801M	$1.0B	$981M	$1.1B
Gross Margin	80.6%	81.1%	84.5%	84.6%	85.3%
R&D Expenses	$13M	$15M	$21M	$24M	$22M
SG&A Expenses	$463M	$404M	$452M	$412M	$429M
Operating Expenses	$475M	$419M	$473M	$436M	$451M
Operating Income	$280M	$382M	$559M	$545M	$609M
Operating Margin	29.9%	38.7%	45.8%	47.0%	49.0%
Interest Expense	$3M	$0	$0	$0	$0
Income Before Tax	$304M	$356M	$579M	$611M	$628M
Tax Expense	$63M	$61M	$101M	$95M	$118M
Net Income	$237M	$291M	$471M	$508M	$501M
Net Margin	25.3%	29.5%	38.5%	43.8%	40.3%
EPS (Diluted)	$1.99	$2.40	$3.87	$4.18	$4.12
EBITDA	$354M	$434M	$608M	$594M	$657M
Shares Outstanding	119M	121M	122M	122M	122M

Line Item	FY2021 Q2	FY2021 Q3	FY2021 Q4	FY2022 Q1	FY2022 Q2	FY2022 Q3	FY2022 Q4	FY2023 Q1
Revenue	$286M	$291M	$302M	$315M	$314M	$317M	$297M	$297M
Cost of Revenue	$45M	$45M	$46M	$48M	$46M	$47M	$42M	$42M
Gross Profit	$241M	$246M	$256M	$267M	$267M	$270M	$255M	$255M
Gross Margin	84.3%	84.6%	84.8%	84.8%	85.3%	85.1%	85.9%	85.9%
R&D Expenses	$5M	$9M	$5M	$5M	$6M	$7M	$5M	-$5M
SG&A Expenses	$97M	$113M	$103M	$106M	$101M	$113M	$108M	-$11M
Operating Expenses	$102M	$122M	$108M	$111M	$107M	$120M	$113M	-$15M
Operating Income	$139M	$124M	$148M	$157M	$160M	$150M	$142M	$142M
Operating Margin	48.7%	42.6%	49.0%	49.7%	51.2%	47.2%	47.8%	47.8%
Interest Expense	$0	$0	$0	$0	$0	$0	$4M	$2M
Income Before Tax	$156M	$139M	$155M	$172M	$156M	$159M	$140M	$140M
Tax Expense	$23M	$21M	$24M	$33M	$28M	$24M	$33M	$33M
Net Income	$131M	$117M	$128M	$136M	$126M	$134M	$105M	$107M
Net Margin	46.0%	40.1%	42.3%	43.3%	40.1%	42.3%	35.2%	35.9%
EPS (Diluted)	$1.08	$0.96	$1.05	$1.12	$1.03	$1.12	$0.86	$0.88
EBITDA	$154M	$138M	$152M	$170M	$154M	$158M	$156M	$142M
Shares Outstanding	122M	121M	122M	122M	122M	121M	122M	122M

CORBF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet